ArticleBMB reports2025

Pluripotent stem cell-derived chimeric antigen receptor-natural killer cells targeting epidermal growth factor receptor 2 for cancer immunotherapy.

Jongsuk Han et al.PubMed ↗Full text ↗

No numbers read from the abstract.